C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Terumo Blood and Cell Technologies Announces Advanced Therapy Manufacturing and Innovation (ATMI) Grant 2020 for Asia Pacific

Tuesday, September 22, 2020

Terumo Blood and Cell Technologies today launches the Advanced Therapy Manufacturing and Innovation ATMI Grant for the Asia Pacific region The ATMI Grant aims to accelerate advanced cell therapy manufacturing and development with an award of up to...

U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

Monday, September 28, 2020

Pfizer Inc announced today that the United States US Food and Drug Administration FDA approved XELJANZ tofacitinib for the treatment of children and adolescents years and older with active polyarticular course juvenile idiopathic arthritis pcJIA Two...

Boehringer Ingelheim and Fraunhofer IME launch collaboration

Wednesday, September 30, 2020

Boehringer Ingelheim and Fraunhofer Institute for Molecular Biology and Applied Ecology IME announce their newly formed collaboration that aims to provide novel microbialbased natural products for development of next generation animal health products...

Applied BioMath, LLC Announces Collaboration with Cullinan Oncology

Wednesday, September 30, 2020

Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Cullinan Oncology

Jellagen ® Ltd announces a collaboration with the Mayo Clinic

Wednesday, September 30, 2020

Jellagen Limited a marine biotechnology company producing highvalue collagen derived from jellyfish has entered into a licensing agreement to grant exclusive patent rights for the development to the Mayo Clinic treatment of vocal cord paralysis

U.S. Food and Drug Administration Approves HAEGARDA® for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients

Monday, September 28, 2020

CSL Behring a global biotherapeutics leader announced today that the US Food and Drug Administration FDA has approved an expanded indication for HAEGARDA C Esterase Inhibitor Subcutaneous Human for routine prophylaxis to prevent hereditary angioedema...

Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test

Monday, September 28, 2020

Quotient Limitedheadquartered in Eysins Switzerland today announced that on September the US Food and Drug Administration FDA issued an Emergency Use Authorization EUA for Quotients COVID antibody test The test detects antibodies generated in human...

AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor

Monday, September 28, 2020

AbbVie today announced that the US Food and Drug Administration FDA has granted Orphan Drug and Fast Track designations for elezanumab ABT an investigational treatment for patients following spinal cord injuryElezanumab is a monoclonal antibody of th...

Sanofi completes Principia Biopharma Inc. acquisition

Tuesday, September 29, 2020

Sanofi announced today the successful completion of its acquisition of Principia Biopharma Inc Principia for per share in cashThe Principia acquisition further strengthens our core areas of autoimmune and allergic diseases giving us full control of...

U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

Monday, September 28, 2020

Pfizer Inc announced today that the United States US Food and Drug Administration FDA approved XELJANZ tofacitinib for the treatment of children and adolescents years and older with active polyarticular course juvenile idiopathic arthritis pcJIA Two...